FDA will hold a virtual public meeting on November 16, 2021, on enhanced drug distribution security at the package level
About this event
System Attributes
Aggregation, Inference, and Physical Security Features
Data Architecture
Adoption of Data and System Security
Protecting Confidential Commercial Information and Trade Secrets
System Access and Data Retrieval
Serialized Transaction Information and Data Exchange (Incorporation of the Product Identifier into Product Tracing Information)
Responsibilities of the Selling and Buying Trading Partners with regard to the Product Tracing Information
Handling Aggregation Errors and Other Discrepancies
Verification of Distributed Product
Verification of Saleable Return Product
Alerts for Illegitimate Product
Your organization’s overall readiness for implementation
Components that your organization is furthest along in developing, including the components being prioritized and the components that are easier or more challenging to implement:
